The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients

[1]  G. Le,et al.  Effect of GABA on oxidative stress in the skeletal muscles and plasma free amino acids in mice fed high-fat diet. , 2015, Journal of animal physiology and animal nutrition.

[2]  A. Fernandes,et al.  Cardiac Energy Metabolism and Oxidative Stress Biomarkers in Diabetic Rat Treated with Resveratrol , 2014, PloS one.

[3]  K. Chandrasekaran,et al.  PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy , 2014, Neurobiology of Disease.

[4]  J. McGavock,et al.  Mechanisms of disease: Mitochondrial dysfunction in sensory neuropathy and other complications in diabetes. , 2014, Handbook of clinical neurology.

[5]  A. Mizisin.  Mechanisms of diabetic neuropathy: Schwann cells. , 2014, Handbook of clinical neurology.

[6]  I. Obrosova.  Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments , 2009, Neurotherapeutics.

[7]  M. Babizhayev,et al.  Advanced drug delivery of N-acetylcarnosine (N-acetyl-beta-alanyl-L-histidine), carcinine (beta-alanylhistamine) and L-carnosine (beta-alanyl-L-histidine) in targeting peptide compounds as pharmacological chaperones for use in tissue engineering, human disease management and therapy: from in vitro t , 2010, Recent patents on drug delivery & formulation.

[8]  R. Freeman,et al.  Diabetic Neuropathy , 2010, Diabetes Care.

[9]  M. Babizhayev,et al.  Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advanced glycation end products. , 2010, Critical reviews in therapeutic drug carrier systems.

[10]  E. Ruuge,et al.  Superoxide formation as a result of interaction of L-lysine with dicarbonyl compounds and its possible mechanism , 2009, Biochemistry (Moscow).

[11]  M. Babizhayev,et al.  N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications , 2009 .

[12]  M. Babizhayev,et al.  N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications. , 2009, Journal of drug targeting.

[13]  M. Aminoff.  Neurology and General Medicine , 2007 .

[14]  G. Suji,et al.  DNA damage during glycation of lysine by methylglyoxal: assessment of vitamins in preventing damage , 2007, Amino Acids.

[15]  F. Naqvi,et al.  Lipid Peroxidation and Serum Antioxidant Enzymes in Patients with Type 2 Diabetes Mellitus , 2006, Annals of the New York Academy of Sciences.

[16]  I. Strokov,et al.  The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. , 2006, Diabetes & metabolism.

[17]  H. Nursten.  The Chemistry of Nonenzymic Browning , 2005 .

[18]  C. Hermenegildo,et al.  Decreased glutathione peroxidase activity in sciatic nerve of alloxan-induced diabetic mice and its correlation with blood glucose levels , 1993, Neurochemical Research.

[19]  D. Wink,et al.  Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[20]  H. Berthoud,et al.  Diabetes and the nervous system , 1981, Diabetologia.

[21]  I. Obrosova.  Update on the pathogenesis of diabetic neuropathy , 2003, Current diabetes reports.

[22]  C. Stehouwer,et al.  Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. , 2003, Biochemical Society transactions.

[23]  J. McArthur,et al.  New insights into diabetic polyneuropathy. , 2003, JAMA.

[24]  J. Baynes,et al.  Maillard reaction products in tissue proteins: New products and new perspectives , 2003, Amino Acids.

[25]  A. Carrascosa,et al.  Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. , 2003, Free radical biology & medicine.

[26]  H. Honma,et al.  Acute glucose deprivation leads to apoptosis in a cell model of acute diabetic neuropathy , 2003, Journal of the peripheral nervous system : JPNS.

[27]  K. Moutairou,et al.  Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. , 2003, General physiology and biophysics.

[28]  E. Feldman.  Oxidative stress and diabetic neuropathy: a new understanding of an old problem. , 2003, The Journal of clinical investigation.

[29]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[30]  E. Feldman,et al.  Diabetic Peripheral and Autonomic Neuropathy , 2003 .

[31]  P. Low,et al.  Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. , 2003, Diabetes.

[32]  T. Gardner,et al.  Diabetic retinopathy: more than meets the eye. , 2002, Survey of ophthalmology.

[33]  J. Olzmann,et al.  High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  J. Rocha,et al.  Oxidative stress in mice is dependent on the free glucose content of the diet. , 2002, The international journal of biochemistry & cell biology.

[35]  M. Ellenberg,et al.  Ellenberg and Rifkin's Diabetes Mellitus , 2002 .

[36]  R. Dean,et al.  Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. , 2002, Archives of biochemistry and biophysics.

[37]  A. Boulton,et al.  Neurovascular disease, antioxidants and glycation in diabetes , 2002, Diabetes/metabolism research and reviews.

[38]  A. Manto,et al.  Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. , 2002, Diabetes care.

[39]  N. Calcutt.  Potential mechanisms of neuropathic pain in diabetes. , 2002, International review of neurobiology.

[40]  Paul J Thornalley.  Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. , 2002, International review of neurobiology.

[41]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[42]  J. Skyler.  Microvascular complications. Retinopathy and nephropathy. , 2001, Endocrinology and metabolism clinics of North America.

[43]  S. Tesfaye,et al.  Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy , 2001, Diabetologia.

[44]  A. Schmidt,et al.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.

[45]  U. de Faire,et al.  A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. , 2001, Free radical biology & medicine.

[46]  A. Barden,et al.  Advanced Glycation End Products: A Review , 2013 .

[47]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[48]  H. Tritschler,et al.  Antioxidants in Diabetes Management , 2000 .

[49]  L. Packer.  Antioxidants in diabetes management , 2000 .

[50]  M. Aviram,et al.  Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM. , 1999, The Israel Medical Association journal : IMAJ.

[51]  S. Greene,et al.  Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with Type 1 diabetes with no clinical vascular disease , 1999, Diabetes/metabolism research and reviews.

[52]  A. Windebank,et al.  Neurons Undergo Apoptosis in Animal and Cell Culture Models of Diabetes , 1999, Neurobiology of Disease.

[53]  A. Vinik.  Diabetic neuropathy: pathogenesis and therapy. , 1999, The American journal of medicine.

[54]  M. Asanuma,et al.  Glial Cells Protect Neurons Against Oxidative Stress via Transcriptional Up‐Regulation of the Glutathione Synthesis , 1999, Journal of neurochemistry.

[55]  S. Apfel.  Neurotrophic Factors and Diabetic Peripheral Neuropathy , 1999, European Neurology.

[56]  S. Apfel.  Nerve regeneration in diabetic neuropathy , 1999, Diabetes, obesity & metabolism.

[57]  U. Faire,et al.  Low yield of polymorphisms from EST blast searching: Analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPX1 , 1999, Human mutation.

[58]  B. Bravenboer,et al.  Nerve function and oxidative stress in diabetic and vitamin E-deficient rats. , 1998, Free radical biology & medicine.

[59]  J. Harding,et al.  Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. , 1997, The Biochemical journal.

[60]  S. Maxwell,et al.  Poor Glycaemic Control is Associated with Reduced Serum Free Radical Scavenging (Antioxidant) Activity in Non-Insulin-Dependent Diabetes Mellitus , 1997, Annals of clinical biochemistry.

[61]  S. Yagihashi,et al.  Localization in human diabetic peripheral nerve of Nɛ-carboxymethyllysine-protein adducts, an advanced glycation endproduct , 1997, Diabetologia.

[62]  P. Fernyhough,et al.  Role of Neurotrophins in Diabetic Neuropathy and Treatment with Nerve Growth Factors , 1997, Diabetes.

[63]  A. Schmidt,et al.  Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress* , 1997, The Journal of Biological Chemistry.

[64]  A. Barnett,et al.  Antioxidant status in patients with uncomplicated insulin‐dependent and non‐insulin‐dependent diabetes mellitus , 1997, European journal of clinical investigation.

[65]  A. Jenkins,et al.  Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. , 1997, The Biochemical journal.

[66]  E. Falleti,et al.  Total Radical-Trapping Antioxidant Parameter in NIDDM Patients , 1997, Diabetes Care.

[67]  E. Feldman,et al.  Pathogenesis of diabetic neuropathy. , 1989, Clinical neuroscience.

[68]  S. Yagihashi,et al.  Localization in human diabetic peripheral nerve of N(epsilon)-carboxymethyllysine-protein adducts, an advanced glycation endproduct. , 1997, Diabetologia.

[69]  P. Dyck,et al.  Pathologic Alterations in the Diabetic Neuropathies of Humans: A Review , 1996, Journal of neuropathology and experimental neurology.

[70]  Paul J Thornalley,et al.  Negative association between erythrocyte reduced glutathione concentration and diabetic complications. , 1996, Clinical science.

[71]  Y. Harati.  Diabetes and the nervous system. , 1996, Endocrinology and metabolism clinics of North America.

[72]  P. Cerutti,et al.  High Glucose Induces Antioxidant Enzymes in Human Endothelial Cells in Culture: Evidence Linking Hyperglycemia and Oxidative Stress , 1996, Diabetes.

[73]  M. Relling,et al.  Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. , 1996, Pharmacogenetics.

[74]  R. Sundaram,et al.  Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. , 1996, Clinical science.

[75]  P. B. Chock,et al.  Free Radicals Generated during the Glycation Reaction of Amino Acids by Methylglyoxal , 1995, The Journal of Biological Chemistry.

[76]  M. Cotter,et al.  Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. , 1995, The Journal of clinical investigation.

[77]  E. Boel,et al.  Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise? , 1995, Journal of diabetes and its complications.

[78]  Paul J Thornalley,et al.  Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. , 1994, The Journal of biological chemistry.

[79]  A. Schmidt,et al.  Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[80]  I. Hirsch,et al.  Reduced Plasma Peroxyl Radical Trapping Capacity and Increased Susceptibility of LDL to Oxidation In Poorly Controlled IDDM , 1994, Diabetes.

[81]  Y. Zou,et al.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. , 1994, The Journal of biological chemistry.

[82]  W. J. Litchy,et al.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.

[83]  T. Lyons,et al.  Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aging a , 1992, Annals of the New York Academy of Sciences.

[84]  Paul J Thornalley.  The glyoxalase system in health and disease. , 1993, Molecular aspects of medicine.

[85]  V. Procacci,et al.  Increased lipid peroxidation in type 2 poorly controlled diabetic patients. , 1992, Diabete & metabolisme.

[86]  V. Monnier,et al.  Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline. , 1992, The Journal of clinical investigation.

[87]  G. Curran,et al.  Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[88]  R. Dean,et al.  Long-lived reactive species on free-radical-damaged proteins. , 1992, Biochemical Journal.

[89]  V. Monnier,et al.  Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. , 1991, Diabetes/metabolism reviews.

[90]  A. Parker,et al.  Reactions of the α‐tocopheroxyl radical in micellar solutions studied by nanosecond laser flash photolysis , 1991 .

[91]  J. Baynes,et al.  Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. , 1991, The Journal of biological chemistry.

[92]  V. Monnier,et al.  Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. , 1991, The Journal of biological chemistry.

[93]  J. Baynes.  Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[94]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[95]  M. Brownlee,et al.  Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. , 1990, Biochemical and biophysical research communications.

[96]  J. Richardson,et al.  Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. , 1990, Biochemistry.

[97]  S. Wolff,et al.  Autoxidative Glycosylation and Possible Involvement of Peroxides and Free Radicals in LDL Modification by Glucose , 1990, Diabetes.

[98]  S. Wolff,et al.  Hydrogen peroxide production during experimental protein glycation , 1990, FEBS letters.

[99]  K. Becker,et al.  Principles and Practice of Endocrinology and Metabolism , 1990 .

[100]  V. Monnier,et al.  End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. , 1990, The Journal of clinical investigation.

[101]  V. Monnier,et al.  Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. , 1989, The Journal of biological chemistry.

[102]  C. Jf,et al.  [Diabetic autonomic neuropathy]. , 1989, Atencion primaria.

[103]  J. Baynes,et al.  Oxidation of glycated proteins: age-dependent accumulation of N epsilon-(carboxymethyl)lysine in lens proteins. , 1989, Biochemistry.

[104]  H. Kato,et al.  3-Deoxyglucosone, an intermediate product of the Maillard reaction. , 1989, Progress in clinical and biological research.

[105]  R. Dean,et al.  Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. , 1988, The Biochemical journal.

[106]  W. Pearson,et al.  Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[107]  M. Hicks,et al.  Catalysis of lipid peroxidation by glucose and glycosylated collagen. , 1988, Biochemical and biophysical research communications.

[108]  S P Wolff,et al.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.

[109]  Peter C Johnson,et al.  Pathogenesis of diabetic neuropathy , 1986, Annals of neurology.

[110]  J. Baynes,et al.  Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. , 1986, The Journal of biological chemistry.

[111]  C. Elmets,et al.  Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. , 1986, The New England journal of medicine.

[112]  Paul J Thornalley.  Monosaccharide autoxidation in health and disease. , 1985, Environmental health perspectives.

[113]  A. Graham,et al.  Direct immunofluorescence findings in peripheral nerve from patients with diabetic neuropathy , 1985, Annals of neurology.

[114]  A. Cerami,et al.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications. , 1984, Annals of internal medicine.

[115]  Paul J Thornalley,et al.  The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. , 1984 .

[116]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[117]  A. Cerami,et al.  Excessive Nonenzymatic Glycosylation of Peripheral and Central Nervous System Myelin Components in Diabetic Rats , 1983, Diabetes.

[118]  P. Watkins.  Diabetic neuropathy--II. , 1982, British medical journal.

[119]  A. Cerami,et al.  Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[120]  R. Pethig,et al.  Spectroscopic studies of the protein-methylglyoxal adduct. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[121]  Y. Ohta,et al.  Electron spin resonance spectral study on the structure of the novel free radical products formed by the reactions of sugars with amino acids or amines. , 1977, Journal of agricultural and food chemistry.

[122]  Y. Ohta,et al.  Novel free radicals formed by the amino-carbonyl reactions of sugars with amino acids, amines, and proteins. , 1977, Advances in experimental medicine and biology.

[123]  Ernest Beutler,et al.  Red Cell Metabolism: A Manual of Biochemical Methods , 1975 .

[124]  E. Beutler.  Red cell metabolism , 1971 .

[125]  T. Reynolds.  Chemistry of nonenzymic browning. II. , 1965, Advances in food research.

[126]  E. Beutler,et al.  Improved method for the determination of blood glutathione. , 1963, The Journal of laboratory and clinical medicine.

[127]  T. Reynolds,et al.  CHEMISTRY OF NONENZYMIC BROWNING. I. THE REACTION BETWEEN ALDOSES AND AMINES. , 1963, Advances in food research.